Synergetics USA (SURG) 3.46 $SURG
Synergetics USA Announces Cooperative Agreement to Develop Next Generation Intraoperative Devices
Marketwire - Mon May 12, 3:06PM CDT
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today announced the completion of a cooperative development agreement with Cleveland Clinic to develop next generation intraoperative devices. These devices are expected to lead to improved visualization of surgical sites leading to more precise tissue targeting and improved surgical outcomes. The agreement calls for Synergetics to provide research and development resources for the collaborative development of specific devices designed for the purpose of significantly advancing the nature of vitreoretinal surgery as it is performed today.
Synergetics USA Announces Launch of Next Generation Directional(TM) II Laser Probe
Marketwire - Mon May 05, 3:39PM CDT
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today announced the launch of the Directional(TM) II Laser Probe.
Synergetics (SURG) in Focus: Stock Tumbles 11.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 7:59AM CDT
Synergetics' shares fell by over 11% on the day. This continues the recent downtrend for SURG, as the stock is down nearly 6% since Feb 13.
Synergetics Reports Second Quarter Fiscal Year 2014 Results
Marketwire - Thu Mar 06, 3:05PM CST
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today reported growth in sales and reported gross profit, operating margin, loss from operations and net loss for the second quarter ended January 31, 2014.
Institutional Investor Share of U.S. Residential Purchases in January Drops to Lowest Level Since March 2012
Marketwire - Wed Feb 26, 11:01PM CST
RealtyTrac(R) (www.realtytrac.com), the nation's leading source for comprehensive housing data, today released its January 2014 Residential & Foreclosure Sales Report, which shows that institutional investors -- defined as entities purchasing at least 10 properties in a calendar year -- accounted for 5.2 percent of all U.S. residential property sales in January, down from 7.9 percent in December and down from 8.2 percent in January 2013.
Synergetics USA Announces Conference Call to Review Second Quarter of Fiscal Year 2014 Results
Marketwire - Thu Feb 20, 8:00AM CST
Synergetics USA, Inc. (NASDAQ: SURG) announced today that it will host a conference call on Thursday, March 6, 2014 at 4:00 p.m. Central Time (5:00 p.m. Eastern) to review the Company's results for the fiscal second quarter ended January 31, 2014. A news release announcing the second quarter's results will be issued on Thursday, March 6, 2014, after market close.
Time to Buy Synergetics (SURG) After Recent Moving Average Crossover? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 30, 5:50AM CST
Time to Buy Synergetics (SURG) After Recent Moving Average Crossover?
Synergetics Reports First Fiscal Quarter 2014 Results
Marketwire - Mon Dec 09, 3:02PM CST
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today reported growth in sales and reported gross profit, operating margin, income from continuing operations and net income for the first quarter ended October 31, 2013.
Synergetics USA Announces Conference Call to Review First Quarter of Fiscal Year 2014 Results
Marketwire - Tue Nov 26, 3:05PM CST
Synergetics USA, Inc. (NASDAQ: SURG) announced today that it will host a conference call on Monday, December 9, 2013 at 4:00 p.m. Central Time (5:00 p.m. Eastern) to review the Company's results for the fiscal first quarter ended October 31, 2013. A news release announcing the first quarter's results will be issued on Monday, December 9, 2013, after market close.
Faruqi & Faruqi, LLP Launches An Investigation Against Synergetics USA, Inc. (SURG) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
Business Wire - Wed Nov 13, 11:24AM CST
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Synergetics USA, Inc. ("Synergetics" or the "Company"
(NasdaqCM: SURG) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders' approval for the Second Amended and Restated Synergetics USA, Inc. 2001 Stock and Performance Incentive Plan.
Synergetics USA Announces Conference Call to Review Fourth Quarter and Fiscal Year 2013 Results
Marketwire - Mon Sep 16, 2:19PM CDT
Synergetics USA, Inc. (NASDAQ: SURG) announced today that it will host a conference call on Tuesday, October 1, 2013 at 4:00 p.m. Central Time (5:00 p.m. Eastern) to review the Company's results for the fiscal fourth quarter and fiscal year ended July 31, 2013. A news release announcing the fourth quarter and fiscal year's results will be issued on Tuesday, October 1, 2013, after market close.
Synergetics USA rises following analyst upgrade
AP - Wed Jul 17, 2:17PM CDT
NEW YORK (AP) — Shares of medical device maker Synergetics USA Inc. jumped Wednesday after a Wunderlich Securities analyst labeled its stock a "Buy."
Upgrade Alert for Synergetics USA (SURG)
Comtex SmarTrend(R) - Wed Jul 17, 7:12AM CDT
Synergetics USA (NASDAQ:SURG) was upgraded from Hold to Buy at Wunderlich today. The stock closed yesterday at $4.00 on volume of 141,000 shares, above average daily volume of 112,000. Over the past year, Synergetics USA has traded in a range of $2.88 to $5.50 and closed yesterday at $4.00, 39% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.7% while the 200-day MA has slid 0.4%.
Synergetics USA Acquires U.K.-Based Distributor M.I.S.S. Ophthalmics Limited
Marketwire - Tue Jul 09, 7:31AM CDT
Synergetics Surgical EU Ltd., an indirect subsidiary of Synergetics USA (NASDAQ: SURG), announced today that it has acquired M.I.S.S. Ophthalmics Limited ("M.I.S.S.", a private ophthalmology distribution company incorporated in England and Wales, for net cash consideration of $2.8 million. M.I.S.S. was Synergetics USA's distributor of ophthalmic products in the U.K., and its wholesale distribution activities contributed approximately $1.1 million in revenue to Synergetics USA in fiscal year 2012. M.I.S.S. generated total revenue of approximately $3.2 million during their fiscal year ended March 31, 2013 and was solidly profitable on an operating basis.
Synergetics Reports Third Quarter of Fiscal 2013 Results
Marketwire - Mon Jun 10, 3:05PM CDT
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today announced results for the third quarter ended April 30, 2013.
Synergetics USA Announces Conference Call to Review Third Quarter of Fiscal Year 2013 Results
Marketwire - Tue May 28, 3:05PM CDT
Synergetics USA, Inc. (NASDAQ: SURG) announced today that it will host a conference call on Monday, June 10, 2013 at 4:00 p.m. Central Time (5:00 p.m. Eastern) to review the Company's results for the fiscal third quarter ended April 30, 2013. A news release announcing the third quarter's results will be issued on Monday, June 10, 2013, after market close.
WEALTHMAKERS.COM Issues Bullish Research Reports on SOQ, SURG, SYBT, SYN, TK, TRNO
M2 - Wed May 22, 10:41AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Sonde Resources Corp (AMEX:SOQ), Synergetics USA Inc (NASDAQ:SURG), S Y Bancorp Inc (NASDAQ:SYBT), Synthetic Biologics Inc (AMEX:SYN), Tinka Resources Ltd (NYSE:TK), Terreno Realty Corp (NYSE:TRNO)
Nasdaq stocks posting largest volume increases
AP - Wed Mar 13, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Downgrade Alert for Synergetics USA (SURG)
Comtex SmarTrend(R) - Wed Mar 13, 8:29AM CDT
Synergetics USA (NASDAQ:SURG) was downgraded from Buy to Hold at Wunderlich today. The stock closed yesterday at $5.07 on volume of 38,000 shares, below average daily volume of 61,000. Synergetics USA, Inc. develops and manufactures medical devices and products for the hospital and healthcare communities. The Company's products include bipolar electrosurgical generators and disposable and non-disposable medical products.
Synergetics USA Announces Cooperative Agreement to Develop Next Generation Intraoperative Devices
Marketwire - Mon May 12, 3:06PM CDT
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today announced the completion of a cooperative development agreement with Cleveland Clinic to develop next generation intraoperative devices. These devices are expected to lead to improved visualization of surgical sites leading to more precise tissue targeting and improved surgical outcomes. The agreement calls for Synergetics to provide research and development resources for the collaborative development of specific devices designed for the purpose of significantly advancing the nature of vitreoretinal surgery as it is performed today.
Synergetics USA Announces Launch of Next Generation Directional(TM) II Laser Probe
Marketwire - Mon May 05, 3:39PM CDT
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today announced the launch of the Directional(TM) II Laser Probe.
Synergetics (SURG) in Focus: Stock Tumbles 11.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 7:59AM CDT
Synergetics' shares fell by over 11% on the day. This continues the recent downtrend for SURG, as the stock is down nearly 6% since Feb 13.
Synergetics Reports Second Quarter Fiscal Year 2014 Results
Marketwire - Thu Mar 06, 3:05PM CST
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today reported growth in sales and reported gross profit, operating margin, loss from operations and net loss for the second quarter ended January 31, 2014.
Institutional Investor Share of U.S. Residential Purchases in January Drops to Lowest Level Since March 2012
Marketwire - Wed Feb 26, 11:01PM CST
RealtyTrac(R) (www.realtytrac.com), the nation's leading source for comprehensive housing data, today released its January 2014 Residential & Foreclosure Sales Report, which shows that institutional investors -- defined as entities purchasing at least 10 properties in a calendar year -- accounted for 5.2 percent of all U.S. residential property sales in January, down from 7.9 percent in December and down from 8.2 percent in January 2013.
Synergetics USA Announces Conference Call to Review Second Quarter of Fiscal Year 2014 Results
Marketwire - Thu Feb 20, 8:00AM CST
Synergetics USA, Inc. (NASDAQ: SURG) announced today that it will host a conference call on Thursday, March 6, 2014 at 4:00 p.m. Central Time (5:00 p.m. Eastern) to review the Company's results for the fiscal second quarter ended January 31, 2014. A news release announcing the second quarter's results will be issued on Thursday, March 6, 2014, after market close.
Time to Buy Synergetics (SURG) After Recent Moving Average Crossover? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 30, 5:50AM CST
Time to Buy Synergetics (SURG) After Recent Moving Average Crossover?
Synergetics Reports First Fiscal Quarter 2014 Results
Marketwire - Mon Dec 09, 3:02PM CST
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today reported growth in sales and reported gross profit, operating margin, income from continuing operations and net income for the first quarter ended October 31, 2013.
Synergetics USA Announces Conference Call to Review First Quarter of Fiscal Year 2014 Results
Marketwire - Tue Nov 26, 3:05PM CST
Synergetics USA, Inc. (NASDAQ: SURG) announced today that it will host a conference call on Monday, December 9, 2013 at 4:00 p.m. Central Time (5:00 p.m. Eastern) to review the Company's results for the fiscal first quarter ended October 31, 2013. A news release announcing the first quarter's results will be issued on Monday, December 9, 2013, after market close.
Faruqi & Faruqi, LLP Launches An Investigation Against Synergetics USA, Inc. (SURG) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
Business Wire - Wed Nov 13, 11:24AM CST
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Synergetics USA, Inc. ("Synergetics" or the "Company"
(NasdaqCM: SURG) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders' approval for the Second Amended and Restated Synergetics USA, Inc. 2001 Stock and Performance Incentive Plan. Synergetics USA Announces Conference Call to Review Fourth Quarter and Fiscal Year 2013 Results
Marketwire - Mon Sep 16, 2:19PM CDT
Synergetics USA, Inc. (NASDAQ: SURG) announced today that it will host a conference call on Tuesday, October 1, 2013 at 4:00 p.m. Central Time (5:00 p.m. Eastern) to review the Company's results for the fiscal fourth quarter and fiscal year ended July 31, 2013. A news release announcing the fourth quarter and fiscal year's results will be issued on Tuesday, October 1, 2013, after market close.
Synergetics USA rises following analyst upgrade
AP - Wed Jul 17, 2:17PM CDT
NEW YORK (AP) — Shares of medical device maker Synergetics USA Inc. jumped Wednesday after a Wunderlich Securities analyst labeled its stock a "Buy."
Upgrade Alert for Synergetics USA (SURG)
Comtex SmarTrend(R) - Wed Jul 17, 7:12AM CDT
Synergetics USA (NASDAQ:SURG) was upgraded from Hold to Buy at Wunderlich today. The stock closed yesterday at $4.00 on volume of 141,000 shares, above average daily volume of 112,000. Over the past year, Synergetics USA has traded in a range of $2.88 to $5.50 and closed yesterday at $4.00, 39% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.7% while the 200-day MA has slid 0.4%.
Synergetics USA Acquires U.K.-Based Distributor M.I.S.S. Ophthalmics Limited
Marketwire - Tue Jul 09, 7:31AM CDT
Synergetics Surgical EU Ltd., an indirect subsidiary of Synergetics USA (NASDAQ: SURG), announced today that it has acquired M.I.S.S. Ophthalmics Limited ("M.I.S.S."
, a private ophthalmology distribution company incorporated in England and Wales, for net cash consideration of $2.8 million. M.I.S.S. was Synergetics USA's distributor of ophthalmic products in the U.K., and its wholesale distribution activities contributed approximately $1.1 million in revenue to Synergetics USA in fiscal year 2012. M.I.S.S. generated total revenue of approximately $3.2 million during their fiscal year ended March 31, 2013 and was solidly profitable on an operating basis. Synergetics Reports Third Quarter of Fiscal 2013 Results
Marketwire - Mon Jun 10, 3:05PM CDT
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today announced results for the third quarter ended April 30, 2013.
Synergetics USA Announces Conference Call to Review Third Quarter of Fiscal Year 2013 Results
Marketwire - Tue May 28, 3:05PM CDT
Synergetics USA, Inc. (NASDAQ: SURG) announced today that it will host a conference call on Monday, June 10, 2013 at 4:00 p.m. Central Time (5:00 p.m. Eastern) to review the Company's results for the fiscal third quarter ended April 30, 2013. A news release announcing the third quarter's results will be issued on Monday, June 10, 2013, after market close.
WEALTHMAKERS.COM Issues Bullish Research Reports on SOQ, SURG, SYBT, SYN, TK, TRNO
M2 - Wed May 22, 10:41AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Sonde Resources Corp (AMEX:SOQ), Synergetics USA Inc (NASDAQ:SURG), S Y Bancorp Inc (NASDAQ:SYBT), Synthetic Biologics Inc (AMEX:SYN), Tinka Resources Ltd (NYSE:TK), Terreno Realty Corp (NYSE:TRNO)
Nasdaq stocks posting largest volume increases
AP - Wed Mar 13, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Downgrade Alert for Synergetics USA (SURG)
Comtex SmarTrend(R) - Wed Mar 13, 8:29AM CDT
Synergetics USA (NASDAQ:SURG) was downgraded from Buy to Hold at Wunderlich today. The stock closed yesterday at $5.07 on volume of 38,000 shares, below average daily volume of 61,000. Synergetics USA, Inc. develops and manufactures medical devices and products for the hospital and healthcare communities. The Company's products include bipolar electrosurgical generators and disposable and non-disposable medical products.
